Dr. Terrence Chen, CEO, United Imaging Intelligence America
The collaboration will empower the innovation and development of robust cardiac technology designed to enhance patient outcomes.
FREMONT, CA: United Imaging, a premier developer of advanced medical imaging and radiotherapy equipment, recently signed a multi-year strategic research relationship with Washington University School of Medicine in St. Louis. United Imaging will collaborate with Washington University, one of the best medical schools in the country, in numerous phases up to five years. It will leverage its uMR 570 system to bolster its research in cardiovascular MR for the enhancement of patient outcomes.
Dr. Terrence Chen, CEO of United Imaging Intelligence America, said, “United Imaging now has a research collaboration with Washington University School of Medicine in St. Louis focused on cardiac MRI applications, including extensive artificial intelligence (AI) capabilities. Specifically, this collaboration leverages AI to simplify and accelerate cMRI workflow and reporting to help broaden clinical availability and decrease health care costs. To assess current patient status and project a clinical course of treatment more accurately, this collaboration will also explore the integration of patient demographics, clinical biomarkers, therapeutic regimens, and prior cMRI studies through developing highly advanced AI technologies.”
United Imaging Healthcare Technology Group has worked toward the improvement of patient outcomes since the year 2011. It offers a complete portfolio of advanced medical imaging and radiotherapy equipment, including medical IT and intelligence solutions. The company is headquartered in Shanghai and has subsidiaries and R&D centers across the US, China, and other parts of the world. It aims to lead healthcare innovation and drive equal access to healthcare for people globally.
The agreement with Washington University School of Medicine in St. Louis will enable United Imaging to revolutionize and improve cardiovascular technology. The academic institution shares the vision of United Imaging in bringing focus to the research efforts on multiple topics that are relevant to the wider population across the world. The collaboration will enable the researchers at Washington University to evaluate the capabilities of cardiac MR in detecting pathological changes in heart tissue before heart function is compromised. The research is designed to assist doctors and give them an opportunity to intervene before the health of the patient deteriorates severely.
Many chemotherapy drugs used for cancer treatment might lead to heart damage, which remains undetected until the development of symptoms in the patient. The research will enable the relevant parties to determine the effectiveness of non-invasive cardiac MR in identifying the changes in heart tissue and predicting severe heart problems in the patient. It will potentially help them in developing a robust technology to facilitate highly detailed information regarding the heart problem, equipping physicians with excellent tools to enhance treatment and improve health outcomes for their patients.
The imaging technology platform of United Imaging, combined with the steadfast commitment of the R&D department, will play a critical role in extracting most benefits from the agreement. The collaboration also involves the utilization of artificial intelligence (AI) in providing quick cardiovascular MR imaging to patients with potentially threatening heart problems. It will also bring a higher level of precision and accuracy into the treatment options.
The uMR is an essential tool which will bolster clinical and scientific research and facilitate the foundation for collaboration through its open hardware platform, sequence platform, and image reconstruction platform. The combined efforts of United Imaging and Washington University School of Medicine in St. Louis, through its research on MR in cardiac treatment, will pave the way for innovation and enhancement of cardiac technology.